Quince Therapeutics (QNCX)

• Market cap: $5.7M
• 1 day: -6.49%
• 5 days: -7.67%
• 1 month: -26.46%
• 3 months: -97.38%
• 6 months: -93.48%
• Year to date: -96.59%
• 1 year: -93.18%
• 5 years: -99.72%
• 10 years: -99.69%
• Sector: Healthcare
• Industry: Biotechnology

About: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Employees: 36